Hazelden Betty Ford Shares Industry-Leading Recovery Outcomes
Center City, Minnesota--(Newsfile Corp. - September 2, 2026) - The nonprofit Hazelden Betty Ford Foundation, a national leader in substance use and mental health care, today released its annual patient outcomes report from the Butler Center for Research—finding that 70% of patients reported abstinence one year after treatment, 75% achieved recovery-capital levels associated with sustained recovery, and more than 85% reported good overall health and quality of life. The report refl
2026-09-02 9:30 AM EDT | Hazelden Betty Ford Foundation
Apptly Commences Trading on the OTCQB and Becomes DTC Eligible
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced that it has been approved to trade on the OTCQB Venture Market ("OTCQB") in the United States under the symbol "ESVNF", effective September 2, 2026. The Company also confirms that its common shares are eligible for electronic clea
2026-09-02 8:00 AM EDT | Apptly Health Technologies Corp.
1329308 B.C. Announces Name Change and Consolidation
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Naia Relief Inc. (formerly, 1329308 B.C. Ltd.) (the "Company") announces that it has changed its name to "Naia Relief Inc." (the "Name Change") and has completed a share consolidation on the basis of 9.0363 pre-consolidation common shares for one (1) post-consolidation common share (the "Consolidation") effective September 1, 2026. The Name Change and Consolidation have been completed in connection with t
2026-09-01 5:13 PM EDT | Naia Relief Inc.
ONE HEMP Commends House Passage of Continuing Resolution, Reinforcing Path Toward Comprehensive Federal Hemp Regulation
Washington, D.C.--(Newsfile Corp. - September 1, 2026) - ONE HEMP today applauded House passage of the Continuing Resolution which included a four-week extension to enact changes to the Farm Bill's definition of hemp. This action, which was previously approved by the Senate, is a significant step toward Congress developing and enacting a sound federal regulatory framework for hemp-derived products. Once the measure is signed into
2026-09-01 4:40 PM EDT | OneHemp
Tersis Technologies and Flux Core Sign MOU to Advance Decentralized Data Centers and Sustainable AI Compute
Miami, Florida--(Newsfile Corp. - September 1, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a clean technology company focused on transforming waste streams into valuable resources, today announced t
Agriculture, Énergie, Énergies de substitution, Santé
2026-09-01 2:33 PM EDT | Tersis Technologies Inc.
Apptly and Koning Announce Strategic Partnership to Expand Patient Access to Non-Compression 3D Breast Imaging
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced a strategic partnership with Koning Corporation ("Koning"), manufacturer of the FDA-approved Koning Vera Breast CT. Highlights: FDA-Approved Breast CT: The Koning Vera Breast CT is the o
2026-09-01 8:00 AM EDT | Apptly Health Technologies Corp.
Delota Reports Financial Results for the Three Months Ended June 30, 2026
Highlights: Total revenue of $8.3 million for Q1 2027 Total System-Wide Revenue of $9.9 million for Q1 2027 33% gross profit margin for Q1 2027 Segmented revenue for Q1 2027: Vape - B2C: $4.0 million, B2B: $3.3 million Cannabis - B2C: $1.0 million Launched 180 Smoke Vape Store Express, a co-branded store-with
Commerce de détail, Cannabis, Santé, Dispensaires de cannabis
2026-09-01 7:00 AM EDT | Delota Corp.
TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece
Highlights: LOI with CPO Greece includes exclusive distribution of VIVI Cap™ and VIVI Epi™ throughout Greece, subject to a definitive agreement. Proposed exclusivity is conditional on minimum annual purchase obligations, with combined purchases required to increase by at least 20% year over year to maintain exclusivity. Transfer pricing and the first-year minimum unit commitment will be negotiated an
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-09-01 6:45 AM EDT | TempraMed Technologies Ltd.
Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its premium functional food brand, Holy Crap Foods Inc. ("Holy Crap"), has officially launched in the U.S. market through the Amazon USA platform. The initial U.S. rollout features two of the brand's top-performing super seed SKUs alongside a popular variety package. Following a strong ini
2026-09-01 6:00 AM EDT | Restart Life Sciences Corp.
Numinus Wellness Inc. Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Numinus Wellness Inc. (OTC Pink: NUMIF) ("Numinus" or the "Company") a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced that it has filed all quarterly interim financial reports for fiscal year 2026 to May 31, 2026. With the re
2026-09-01 5:39 AM EDT | Numinus Wellness Inc.
Altrova Health Reports Third Quarter Fiscal 2026 Financial Results
Toronto, Ontario--(Newsfile Corp. - August 31, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") today announced its financial results for the three and nine-month periods ended June 30, 2026 ("Q3 Fiscal 2026"). The Company's condensed interim consolidated financial statements and related management's discussion and analysis for the period (collectively, the "Interim Filings") have been filed under the Company's p
2026-08-31 6:37 PM EDT | Altrova Health Inc.
Rhelion Life Sciences Reports First Quarter 2027 Results
Toronto, Ontario--(Newsfile Corp. - August 31, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to report its financial and operational results for the three months ended June 30, 2026 ("Q1 2027"), capping a transitional quarter which culminated in the acquisition of Filament Health Corp. ("Filament"). All figures are reported
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-08-31 8:39 AM EDT | Rhelion Life Sciences Corp.
BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotechnology company developing BETR-001 for the treatment of migraine and headache disorders, is pleased to announce the appointment of Charles Duncan, PhD as Director and Chair of the Audit Committee. Dr. Duncan is a biotechnology strategist, board director and former top-ranked Wall Street biotechnology anal
2026-08-31 8:00 AM EDT | BetterLife Pharma Inc.
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team
Winter Park, Florida--(Newsfile Corp. - August 31, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and advanced clinical services, today announced that its introductory innovation session earlier this month at Full Sail University delivered exactly the spark the Company was looking for — and that Adia Med has already assembled a social media team of interns to convert that momentum into a new era of organic marketing.
Soins de santé et hôpitaux, Santé
2026-08-31 8:00 AM EDT | Adia Med Inc.
Cheelcare Announces Fourth Quarter and Fiscal 2026 Financial Results and Provides Curio Update
Markham, Ontario--(Newsfile Corp. - August 31, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial results for the fourth quarter and fiscal year ended April 30, 2026. All figures are in CAD unless otherwise noted. Operational Highlights (Year Ended April 30, 2026) Continued revenue and Companion sales growth: Fiscal 2026 revenue increased 22% year-ove
2026-08-31 7:30 AM EDT | Cheelcare Inc.
DiagnosTear Technologies Inc. Announces Private Placement of Units
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company") is pleased to announce it will be proceeding with a non-brokered private placement of up to 2,800,000 units ("Units") at a price of C$0.50 per Unit for aggregate gross proceeds of up to C$1,400,000 (the "Offering"). The Company expects BioLight Life Sciences Ltd., parent company of DiagnosTear, and Elcam Medic
2026-08-31 7:00 AM EDT | DiagnosTear Technologies Inc.
Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
Montreal, Quebec--(Newsfile Corp. - August 31, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® technology, is pleased to announce the expansion of its radiopharmaceutical development program to evaluate alpha-emitting and beta-emitting radioisotopes. This expansion is to broaden the capabi
Biotechnologies, Pharmaceutique, Santé
2026-08-31 3:15 AM EDT | Defence Therapeutics Inc.
Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update
Q4 Fiscal 2025 Highlights Revenue of $2.3 million, a 29.0% increase over Q3 2025 Gross profit of $1.4 million, compared to a gross profit of $0.8 million in Q3 2025 Cash position of $0.5 million as of August 31, 2025 Subsequent to Quarter End On April 18, 2026, President Donald Trump signed an executive order directing U.S. federal agencies to accelerate research, acce
2026-08-28 5:00 PM EDT | Numinus Wellness Inc.
BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, is pleased to announce today that it has priced its previously announced public offering (the "Offering") of common shares of the Company ("Commo
2026-08-28 8:00 AM EDT | BetterLife Pharma Inc.
NuGen Announces Filing of Corrective Disclosure Pursuant to OSC Review
Toronto, Ontario--(Newsfile Corp. - August 27, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that further to the review by the Ontario Securities Commission ("OSC") of the Company's continuous disclosure, the Company has made corrective disclosure with respect to the following: the Company has included in its recently filed management information circular dated August 17, 2026 (the "Circul
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-08-27 5:30 PM EDT | NuGen Medical Devices Inc.